Pacific Biosciences of California Inc (NASDAQ:PACB) traded at $1.60 at close of the session on Monday, April 29, made an upward move of 8.84% on its previous day’s price.
Looking at the stock we see that its previous close was $1.47. In terms of its 52-week price range, PACB has a high of $14.55 and a low of $1.25. The company’s stock has lost about -57.33% over that past 30 days.
Pacific Biosciences of California Inc has a market cap of $435.65 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.27, with the EPS growth for the year raised at -$1.02 for 2024 and -$0.82 for next year. These figures represent 15.70% and 19.60% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $42.96 million, with a low of $38.75 million and a high of $51.4 million. The median projection represents growth squeezing down to 25.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $204.67 million, or 2.10% up from figures reported last year.
On the other hand, looking at the outlook for the PACB stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -35.90% off its SMA20 and -57.01% from its 50-day simple moving average. The RSI (14) is pointing at 27.27 while the volatility over the past week is 12.74% and jumps to 12.62% over the past one month. The beta value is 1.96, while the average true range (ATR) is currently pointing at 0.30.
Coming back to Pacific Biosciences of California Inc (NASDAQ:PACB), we note that the average 3-month trading volume was 9.72 million. Current shares outstanding are 267.74 million.
The insiders hold 6.08% of the company’s shares while institutions hold 102.32%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -83.69% down in year-to-date price movement.
